Suppr超能文献

组织和肿瘤中的全基因组加倍。

Whole-genome doubling in tissues and tumors.

机构信息

Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06510, USA.

Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

出版信息

Trends Genet. 2023 Dec;39(12):954-967. doi: 10.1016/j.tig.2023.08.004. Epub 2023 Sep 14.

Abstract

The overwhelming majority of proliferating somatic human cells are diploid, and this genomic state is typically maintained across successive cell divisions. However, failures in cell division can induce a whole-genome doubling (WGD) event, in which diploid cells transition to a tetraploid state. While some WGDs are developmentally programmed to produce nonproliferative tetraploid cells with specific cellular functions, unscheduled WGDs can be catastrophic: erroneously arising tetraploid cells are ill-equipped to cope with their doubled cellular and chromosomal content and quickly become genomically unstable and tumorigenic. Deciphering the genetics that underlie the genesis, physiology, and evolution of whole-genome doubled (WGD) cells may therefore reveal therapeutic avenues to selectively eliminate pathological WGD cells.

摘要

绝大多数增殖的体细胞核型为二倍体,这种基因组状态通常在连续的细胞分裂中得以维持。然而,细胞分裂的失败会导致全基因组加倍(WGD)事件,使二倍体细胞转变为四倍体状态。虽然有些 WGD 是为了产生具有特定细胞功能的非增殖性四倍体细胞而进行的发育编程,但非计划的 WGD 可能是灾难性的:错误出现的四倍体细胞无法应对其两倍的细胞和染色体含量,很快就会变得基因组不稳定并癌变。因此,阐明全基因组加倍(WGD)细胞的发生、生理和进化的遗传学基础,可能会揭示出选择性消除病理性 WGD 细胞的治疗途径。

相似文献

1
Whole-genome doubling in tissues and tumors.组织和肿瘤中的全基因组加倍。
Trends Genet. 2023 Dec;39(12):954-967. doi: 10.1016/j.tig.2023.08.004. Epub 2023 Sep 14.
8
Genome duplication in a long-term multicellularity evolution experiment.长期多细胞性进化实验中的基因组加倍
Nature. 2025 Mar;639(8055):691-699. doi: 10.1038/s41586-025-08689-6. Epub 2025 Mar 5.

引用本文的文献

2
Genome duplication in a long-term multicellularity evolution experiment.长期多细胞性进化实验中的基因组加倍
Nature. 2025 Mar;639(8055):691-699. doi: 10.1038/s41586-025-08689-6. Epub 2025 Mar 5.
6
Integrating the Study of Polyploidy Across Organisms, Tissues, and Disease.整合多倍体在生物体、组织和疾病中的研究。
Annu Rev Genet. 2024 Nov;58(1):297-318. doi: 10.1146/annurev-genet-111523-102124. Epub 2024 Nov 14.
7
Cell-cell fusion in cancer: The next cancer hallmark?细胞融合与癌症:下一个癌症标志?
Int J Biochem Cell Biol. 2024 Oct;175:106649. doi: 10.1016/j.biocel.2024.106649. Epub 2024 Aug 24.

本文引用的文献

2
Heritable transcriptional defects from aberrations of nuclear architecture.核架构异常导致的可遗传性转录缺陷。
Nature. 2023 Jul;619(7968):184-192. doi: 10.1038/s41586-023-06157-7. Epub 2023 Jun 7.
3
Epigenetic dysregulation from chromosomal transit in micronuclei.微核中染色体转运引起的表观遗传失调。
Nature. 2023 Jul;619(7968):176-183. doi: 10.1038/s41586-023-06084-7. Epub 2023 Jun 7.
5
Mitotic clustering of pulverized chromosomes from micronuclei.粉碎微核染色体的有丝分裂聚类。
Nature. 2023 Jun;618(7967):1041-1048. doi: 10.1038/s41586-023-05974-0. Epub 2023 May 10.
7
The evolution of two transmissible cancers in Tasmanian devils.塔斯马尼亚恶魔的两种传染性癌症的进化。
Science. 2023 Apr 21;380(6642):283-293. doi: 10.1126/science.abq6453. Epub 2023 Apr 20.
9
The evolution of non-small cell lung cancer metastases in TRACERx.TRACERx 中观察到的非小细胞肺癌转移演变。
Nature. 2023 Apr;616(7957):534-542. doi: 10.1038/s41586-023-05729-x. Epub 2023 Apr 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验